JAMA Publishes Two Large Studies Demonstrating the Diagnostic Accuracy of EarliTec’s Evaluation for Autism Spectrum Disorder in Children as Young as 16 Months
Retrieved on:
Tuesday, September 5, 2023
General Health, Health, Mental Health, Medical Devices, Children, Genetics, Consumer, Other Health, Autism Science Foundation, Georgia Research Alliance, Emory University School of Medicine, National Institute of Mental Health, Parent, Mental health, Multimedia, Medicine, Research, Doctor of Philosophy, Associate, Marcus Foundation, Science, American Medical Association, Professor, Gold, Journal, Behavior, Joseph, MD, JAMA Network Open, Risk, Spectrum, Assessment, Diagnosis, Ageing, Social visualization, Foundation (nonprofit), Medical imaging, Pharmaceutical industry, Management, Child
View the full release here: https://www.businesswire.com/news/home/20230905447529/en/
Key Points:
- View the full release here: https://www.businesswire.com/news/home/20230905447529/en/
"The demand for earlier and accessible autism diagnosis and objective assessment measures is great,” said Sreeni Narayanan, Chief Technology Officer of EarliTec. - The multi-site, prospective, double-blind study included 475 participants aged 16 to 30 months.
- The EarliPointTM Evaluation’s diagnostic performance had 0.90 (95% CI: 0.87-0.94) area under the receiver-operating characteristic curve, sensitivity of 78.0% (95% CI: 70.7%-83.9%), and specificity of 85.4% (79.5%-89.8%).
- Over the years, additional research support was provided by the National Institute of Mental Health, the Joseph B. Whitehead Foundation, and the Georgia Research Alliance.